Thomas Najarian

967 total citations · 1 hit paper
11 papers, 647 citations indexed

About

Thomas Najarian is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Clinical Psychology. According to data from OpenAlex, Thomas Najarian has authored 11 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Clinical Psychology. Recurrent topics in Thomas Najarian's work include Pharmacology and Obesity Treatment (4 papers), Eating Disorders and Behaviors (2 papers) and Obsessive-Compulsive Spectrum Disorders (2 papers). Thomas Najarian is often cited by papers focused on Pharmacology and Obesity Treatment (4 papers), Eating Disorders and Behaviors (2 papers) and Obsessive-Compulsive Spectrum Disorders (2 papers). Thomas Najarian collaborates with scholars based in United States. Thomas Najarian's co-authors include David B. Allison, Kishore M. Gadde, W. Timothy Garvey, Barbara Troupin, Wesley Day, Michael Schwiers, PETER Y. TAM, Craig A. Peterson, Theodore Colton and Carlos A. Roldan and has published in prestigious journals such as The Lancet, Circulation and Obesity.

In The Last Decade

Thomas Najarian

10 papers receiving 606 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP)

2011 486 citations David B. Allison, Kishore M. Gadde et al. Obesity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Najarian United States	7	467	351	244	74	57	11	647
Bernard Job France	4	339 0.7×	246 0.7×	126 0.5×	159 2.1×	18 0.3×	7	619
Altynai Satylganova Denmark	9	342 0.7×	471 1.3×	246 1.0×	153 2.1×	30 0.5×	12	780
Tamer Coskun United States	3	356 0.8×	566 1.6×	292 1.2×	157 2.1×	14 0.2×	6	787
Maria Kabisch Germany	4	268 0.6×	396 1.1×	177 0.7×	163 2.2×	25 0.4×	7	766
Andrea M. Metzig United States	12	149 0.3×	195 0.6×	128 0.5×	84 1.1×	34 0.6×	15	505
Sirel Gurbuz United States	5	430 0.9×	677 1.9×	341 1.4×	192 2.6×	15 0.3×	7	921
Scheen Aj Belgium	8	162 0.3×	296 0.8×	133 0.5×	102 1.4×	8 0.1×	57	578
Signe Olrik Rytter Wallenstein United States	5	428 0.9×	537 1.5×	214 0.9×	130 1.8×	28 0.5×	9	717
Louise Færch Denmark	7	414 0.9×	720 2.1×	239 1.0×	240 3.2×	18 0.3×	16	930
Anna Koroleva Denmark	6	498 1.1×	617 1.8×	254 1.0×	151 2.0×	34 0.6×	12	863

Countries citing papers authored by Thomas Najarian

Since Specialization

Citations

This map shows the geographic impact of Thomas Najarian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Najarian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Najarian more than expected).

Fields of papers citing papers by Thomas Najarian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Najarian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Najarian. The network helps show where Thomas Najarian may publish in the future.

Co-authorship network of co-authors of Thomas Najarian

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Najarian. A scholar is included among the top collaborators of Thomas Najarian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Najarian. Thomas Najarian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Safer, Debra L., et al.. (2024). Do early indicators of euthyroid sick syndrome predict later post-bariatric weight loss? Exploring a novel hypothesis. Medical Hypotheses. 183. 111256–111256.

2.

Safer, Debra L., Sarah Adler, Shebani Sethi, et al.. (2019). A randomized, placebo‐controlled crossover trial of phentermine‐topiramate ER in patients with binge‐eating disorder and bulimia nervosa. International Journal of Eating Disorders. 53(2). 266–277. 34 indexed citations

3.

Sethi, Shebani, Sarah Adler, Thomas Najarian, & Debra L. Safer. (2017). Study protocol and rationale for a randomized double-blinded crossover trial of phentermine-topiramate ER versus placebo to treat binge eating disorder and bulimia nervosa. Contemporary Clinical Trials. 64. 173–178. 8 indexed citations

4.

Adler, Sarah, et al.. (2016). Maladaptive Hypothyroidism, or The Famine Response, After Bariatric Surgery: TSH not the Gold Standard For Detection. Surgery for Obesity and Related Diseases. 12(7). s118–s119. 1 indexed citations

5.

Allison, David B., Kishore M. Gadde, W. Timothy Garvey, et al.. (2011). Controlled‐Release Phentermine/Topiramate in Severely Obese Adults: A Randomized Controlled Trial (EQUIP). Obesity. 20(2). 330–342. 486 indexed citations breakdown →

6.

Najarian, Thomas, et al.. (2011). TSH is Not the Answer: Rationale for a New Paradigm to Evaluate and Treat Hypothyroidism, Particularly Associated with Weight Loss. 1 indexed citations

7.

Najarian, Thomas & Thomas W. Traut. (2000). Nifedipine and Nimodipine Competitively Inhibit Uridine Kinase and Orotidine-Phosphate Decarboxylase: Theoretical Relevance to Poor Outcome in Stroke. Neurorehabilitation and neural repair. 14(3). 237–241. 9 indexed citations

8.

Shively, Bruce K., et al.. (1999). Prevalence and Determinants of Valvulopathy in Patients Treated With Dexfenfluramine. Circulation. 100(21). 2161–2167. 56 indexed citations

9.

Najarian, Thomas. (1983). [Alternative Interpretations of Statistics on Health Effects of Low-Level Radiation]: Comment. The American Statistician. 37(4). 455–455. 1 indexed citations

10.

Najarian, Thomas, et al.. (1981). Hematologic Effect of cis-Platinum-Bleomycin Therapy. Oncology. 38(4). 195–197. 6 indexed citations

11.

Najarian, Thomas & Theodore Colton. (1978). MORTALITY FROM LEUKÆMIA AND CANCER IN SHIPYARD NUCLEAR WORKERS. The Lancet. 311(8072). 1018–1020. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact